Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD274 | Q9NZQ7 | 10/20 | 0.33 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.32 |
| ▸ | VSIR | Q9H7M9 | 2/20 | 0.31 |
| ▸ | PDCD1 | Q15116 | 2/20 | 0.31 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.31 |
| ▸ | S1PR3 | Q99500 | 3/20 | 0.31 |
| ▸ | TRPV3 | Q8NET8 | 2/20 | 0.30 |
| ▸ | LTA4H | P09960 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29190064 | 1.00 | CD274 (0.33) | CD274PDCD1LG2VSIRPDCD1S1PR1 | |
| SCHEMBL29190124 | 0.95 | CD274 (0.33) | CD274PDCD1LG2VSIRPDCD1S1PR1 | |
| SCHEMBL29190125 | 0.95 | CD274 (0.33) | CD274PDCD1LG2VSIRPDCD1S1PR1 | |
| SCHEMBL29190090 | 0.93 | CD274 (0.35) | CD274PDCD1S1PR1S1PR3TRPV3 | |
| SCHEMBL29190092 | 0.93 | CD274 (0.35) | CD274PDCD1S1PR1S1PR3TRPV3 | |
| SCHEMBL29190054 | 0.92 | CD274 (0.35) | CD274PDCD1LG2VSIRPDCD1TRPV3 | |
| SCHEMBL29190053 | 0.92 | CD274 (0.35) | CD274PDCD1LG2VSIRPDCD1TRPV3 | |
| SCHEMBL29189879 | 0.90 | CD274 (0.34) | CD274PDCD1LG2VSIRPDCD1TRPV3 | |
| SCHEMBL29189877 | 0.90 | CD274 (0.34) | CD274PDCD1LG2VSIRPDCD1TRPV3 | |
| SCHEMBL29190045 | 0.90 | CD274 (0.34) | CD274PDCD1LG2VSIRPDCD1LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117858865-A | CBL-B modulators and uses thereof | 林伯士克莱奥公司 | 2024-04-09 | — | — | CN | disclosed |